Antineutrophil cytoplasmic antibodies.

Area of Science:

• Immunology
• Rheumatology
• Nephrology

Background:

• Antineutrophil cytoplasmic antibodies (ANCA) are crucial serological markers for diagnosing small-vessel vasculitides.
• Conditions like Wegener's granulomatosis and microscopic polyangiitis show high ANCA prevalence (85-95%).
• The diagnostic and pathogenic roles of ANCA are significant, though not fully elucidated for all types.

Purpose of the Study:

• To highlight the diagnostic utility of ANCA in small-vessel vasculitis.
• To discuss the potential of ANCA in disease monitoring.
• To explore the pathogenic role of ANCA and its implications for treatment.

Main Methods:

• Serological testing for ANCA detection.
• Clinical data analysis of patients with small-vessel vasculitis.
• Review of existing literature on ANCA pathogenesis and treatment.

Main Results:

• ANCA are present in 85-95% of patients with Wegener's granulomatosis, microscopic polyangiitis, and pauci-immune glomerulonephritis.
• Proteinase 3 and myeloperoxidase ANCA are clinically relevant.
• Evidence supports a pathogenic role for ANCA in vasculitis.

Conclusions:

• ANCA are valuable diagnostic and potentially monitoring tools for small-vessel vasculitis.
• Further understanding of ANCA pathogenesis can lead to improved therapeutic strategies.
• Current treatments have limitations, emphasizing the need for targeted approaches based on ANCA understanding.